Peregrine Pharma (PPHM) Reports Q4 Loss of $0.16/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
- Citi cuts investment banking analyst program to two years - Bloomberg
- Paramount Skydance to close WBD deal, change ticker to SKYD
- Nasdaq notches record high close as investors focus on earnings
- This multi-trillion stock is "cheap and getting cheaper": Morgan Stanley
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
Peregrine Pharmaceuticals Reports Financial Results for Quarter and Fiscal Year Ended April 30, 2017 and Recent Developments
July 14, 2017 4:13 PM EDT-- Avid Achieves Year-Over-Year Topline Revenue Growth of 30% Exceeding $57 Million --
Modified from Kallinteris NL et. al., AACR 2017-- Recent Presentation Supports Bavituximabs... More



